Your browser doesn't support javascript.
loading
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report.
Vita, Serena; D'Abramo, Alessandra; Coppola, Andrea; Farroni, Chiara; Iori, Anna Paola; Faraglia, Francesca; Sette, Alessandro; Grifoni, Alba; Lindestam Arlehamn, Cecilia; Bibas, Michele; Goletti, Delia; Nicastri, Emanuele.
Afiliação
  • Vita S; Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • D'Abramo A; Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Coppola A; Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Farroni C; Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Iori AP; Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
  • Faraglia F; Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, United States.
  • Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, United States.
  • Lindestam Arlehamn C; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, United States.
  • Bibas M; Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Goletti D; Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Nicastri E; Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Front Oncol ; 14: 1290614, 2024.
Article em En | MEDLINE | ID: mdl-38414746
ABSTRACT
Here we describe the case of a 51 years old Italian woman with acute lymphoblastic leukemia who underwent to hematopoietic stem cell transplantation (HSCT) during SARS-COV-2 infection. She presented a prolonged COVID-19 successfully treated with dual anti SARS-COV-2 antiviral plus monoclonal antibody therapy.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália